Is PD-L1 a consistent biomarker for anti-PD-1 therapy? The model of balstilimab in a virally-driven tumor

por Grossman, Joseph E., Vasudevan, Divya, Joyce, Cailin E., Hildago, Manuel
Publicado 2021

A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the Pancreas

por Hidalgo, Manuel, Garcia-Carbonero, Rocio, Lim, Kian-Huat, Messersmith, Wells A., Garrido-Laguna, Ignacio, Borazanci, Erkut, Lowy, Andrew M., Medina Rodriguez, Laura, Laheru, Daniel, Salvador-Barbero, Beatriz, Malumbres, Marcos, Shields, David J., Grossman, Joseph E., Huang, Xin, Tammaro, Meggan, Martini, Jean-François, Yu, Yanke, Kern, Kenneth, Macarulla, Teresa
Publicado 2022

A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in Pancreatic Cancer

por Bockorny, Bruno, Muthuswamy, Lakshmi, Huang, Ling, Hadisurya, Marco, Lim, Christine Maria, Tsai, Leo L., Gill, Ritu R., Wei, Jesse L., Bullock, Andrea J., Grossman, Joseph E., Besaw, Robert J., Narasimhan, Supraja, Tao, W. Andy, Perea, Sofia, Sawhney, Mandeep S., Freedman, Steven D., Hidalgo, Manuel, Iliuk, Anton, Muthuswamy, Senthil K.
Publicado 2023